Trials / Completed
CompletedNCT01850446
Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
Comparative Parallel-group Randomized Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Materia Medica Holding · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is: * to assess the efficacy of Ergoferon in treatment of influenza; * to assess the safety of Ergoferon in treatment of influenza; * to compare the efficacy of Ergoferon and Oseltamivir for treatment of influenza.
Detailed description
The overall duration of a patient participation in the trial is 6 days (screening/randomization/therapy onset - day 1; study therapy period - day 1-5; follow-up period - day 6).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ergoferon | Safety and Efficacy |
| DRUG | Oseltamivir | Safety and Efficacy |
Timeline
- Start date
- 2015-02-20
- Primary completion
- 2018-04-16
- Completion
- 2018-04-16
- First posted
- 2013-05-09
- Last updated
- 2020-04-16
- Results posted
- 2020-04-03
Locations
7 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT01850446. Inclusion in this directory is not an endorsement.